Documents - Marketing authorisation medicines for human use

46 documents Marketing authorisation medicines for human use

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a document or publication you are looking for, such as press releases or speeches.
Sort by:
Only subscribe to documents from this organisation
  1. Manual parallel import dossier structure

    Policy document | 01-06-2015

  2. Schrijfadviezen voor de geneesmiddelenbijsluiter

    Policy document | 01-01-2015

  3. MEB 15: Replica marketing authorisation (only apply to existing marketing authorisations)

    A replica marketing authorisation concerns a medicinal product which is exactly the same as the reference medicinal product, with ...

    Policy document | 28-10-2014

  4. Disinfectant products: Distinguishing between biocidal products and medicinal products (human and veterinary)

    Policy document | 01-05-2013

  5. MEB 39: Policy for assigning RVG numbers

    This document describes the Medicines Evaluation Board policy for assigning RVG numbers. This policy is based on the definitions ...

    Policy document | 31-08-2012

  6. Assessment report coagulated potato protein and hydrolysates, applicant AVEBE

    A report on the assessment of the substantial equivalence of coagulated potato protein and hydrolysates by the company AVEBE with ...

    Report | 20-07-2000